These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 36633399

  • 1. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy.
    Faroni E, Sabattini S, Guerra D, Iannuzzi C, Chalfon C, Agnoli C, Stefanello D, Polton G, Ramos S, Aralla M, Ciaccini R, Foglia A, Okonji S, Marconato L.
    Vet Comp Oncol; 2023 Mar; 21(1):123-130. PubMed ID: 36633399
    [Abstract] [Full Text] [Related]

  • 2. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE, Liptak JM, Gall TT, Monteith GJ, Woods JP.
    J Am Vet Med Assoc; 2007 Nov 15; 231(10):1550-7. PubMed ID: 18021000
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma.
    Story AL, Wavreille V, Abrams B, Egan A, Cray M, Selmic LE.
    Vet Surg; 2020 Aug 15; 49(6):1154-1163. PubMed ID: 32562436
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
    Moore AS, Rassnick KM, Frimberger AE.
    J Am Vet Med Assoc; 2017 Sep 01; 251(5):559-565. PubMed ID: 28828962
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
    Kahn SA, Mullin CM, de Lorimier LP, Burgess KE, Risbon RE, Fred RM, Drobatz K, Clifford CA.
    Can Vet J; 2013 Mar 01; 54(3):237-42. PubMed ID: 23997259
    [Abstract] [Full Text] [Related]

  • 10. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP, Orbell G, Cave N, Munday JS.
    J Small Anim Pract; 2018 Feb 01; 59(2):85-91. PubMed ID: 29210452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
    Treggiari E, Borrego JF, Gramer I, Valenti P, Harper A, Finotello R, Toni C, Laomedonte P, Romanelli G.
    Vet Comp Oncol; 2020 Mar 01; 18(1):43-51. PubMed ID: 31648405
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A, Salah P, Mahoney JA, Krick E, Martins R, Scavello H, Lenz JA, Atherton MJ.
    Vet Comp Oncol; 2022 Sep 01; 20(3):688-696. PubMed ID: 35442554
    [Abstract] [Full Text] [Related]

  • 14. The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma.
    Alexander CK, Cronin KL, Silver M, Gardner HL, London C.
    J Small Anim Pract; 2019 Jan 01; 60(1):32-37. PubMed ID: 30209807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Surgery and doxorubicin in dogs with hemangiosarcoma.
    Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ.
    J Vet Intern Med; 1996 Jan 01; 10(6):379-84. PubMed ID: 8947871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review.
    MacEwen EG, Kurzman ID, Helfand S, Vail D, London C, Kisseberth W, Rosenthal RC, Fox LE, Keller ET, Obradovich J.
    J Drug Target; 1994 Jan 01; 2(5):391-6. PubMed ID: 7704483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.